Comparison of the combination of valsartan 320 mg plus hydrochlorothiazide 12.5 mg and valsartan 320 mg plus hydrochlorothiazide 25 mg to valsartan 320 mg in mild to moderate hypertensive patients not adequately controlled with valsartan 320 mg
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Hydrochlorothiazide; Valsartan
- Indications Hypertension
- Focus Therapeutic Use
- 07 Nov 2011 Actual patient number is 2714 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (July 2005) added as reported by ClinicalTrials.gov.
- 13 Nov 2005 New trial record.